FGF23 and hypophosphatemia: The “Iron and Phosphaturia – ExplorIRON-CKD” study was primarily designed to explore the differential effect of FDI and FCM on fibroblast growth factor 23 (FGF23) and markers relevant to hypophosphatemia and bone metabolism.